デフォルト表紙
市場調査レポート
商品コード
1404670

ウェアラブル注入器の市場規模、シェア、動向分析レポート:タイプ別、技術別、最終用途別、用途別、地域別、セグメント別予測、2024年~2030年

Wearable Injectors Market Size, Share & Trends Analysis Report By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven), By End-use (Hospitals, Clinics), By Application (Oncology), By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
ウェアラブル注入器の市場規模、シェア、動向分析レポート:タイプ別、技術別、最終用途別、用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2023年11月15日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ウェアラブル注入器市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、ウェアラブル注入器の世界市場規模は、2024年から2030年にかけてCAGR 18.11で拡大し、2030年には238億9,000万米ドルに達すると予測されています。

同市場は、24時間モニタリング需要の高まりとウェアラブルインジェクタの技術進歩により、予測期間中に有利な成長が見込まれます。

ウェアラブル注入器の技術的進歩、例えば、Bluetooth一体型ウェアラブル注入器は、注射のリマインダーや治療体制に関するデータなどのアラートを患者に送信します。また、オプションのスマート機能により、ヘルスケア・ネットワークに接続することができます。これらの機器には、衣服からアクセスできるボタンがあり、誤作動を防ぐ機器もあります。また、可聴および視覚的なステータスインジケータやシグナルを備えているものもあります。患者は、静脈内投与や他の経路と比較して、最小限の時間と労力で薬剤を皮下自己投与することができます。患者は投与のためにヘルスケアプロバイダーを訪れる必要はないです。

糖尿病や高血圧などの生活習慣病の流行は、予測期間中に増加すると予想されます。これらの疾患では、血圧や血糖値など様々な生理的パラメーターを24時間モニタリングする必要があります。これらのデバイスの高度なエコシステムは、ヘルスケア提供者が遠隔地からデータにアクセスするのを助け、臨床判断時間を短縮します。このように、ヘルスケアデータとウェアラブル注入器の統合は、医師や医師に転送され、エラーを減らしながらデータにリアルタイムでアクセスできるようになり、ウェアラブル注入器市場を押し上げると期待されています。

ウェアラブル注入器市場レポートハイライト:

  • オンボディウェアラブル注入器は、薬剤を簡便に放出し、皮膚に装着できる粘着パッチに対する患者の嗜好の高まりにより、2023年に最大の収益シェアを占めました。
  • モーター駆動型セグメントは、病院、診療所、小売チェーン店、薬局からの需要の増加により、予測期間中に最も高い成長を記録すると予想されています。
  • がん分野は、世界のがん罹患率の増加により、最大の市場シェアを占めると予想されます。
  • 在宅ケア分野は、COVID-19パンデミックの発症による在宅治療への傾倒の高まりが見られ、在宅ケア分野の成長にプラスの影響を与えているため、最も高い市場シェアで市場を独占すると予想されます。
  • 北米は2023年に33.2%の最大売上シェアを占めました。これは、慢性・生活習慣病有病率の上昇とヘルスケアインフラの増強に起因しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ウェアラブル注入器の市場変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ウェアラブル注入器市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 ウェアラブル注入器市場:タイプ推定・動向分析

  • ウェアラブル注入器市場:重要なポイント
  • ウェアラブル注入器市場:変動と市場シェア分析、2023年と2030年
  • オンボディ
  • オフボディ

第5章 ウェアラブル注入器市場:技術推定・動向分析

  • ウェアラブル注入器市場:重要なポイント
  • ウェアラブル注入器市場:変動と市場シェア分析、2023年と2030年
  • スプリングベース
  • モーター駆動
  • ロータリーポンプ
  • バッテリーの拡張
  • その他

第6章 ウェアラブル注入器市場:用途推定・動向分析

  • ウェアラブル注入器市場:重要なポイント
  • ウェアラブル注入器市場:変動と市場シェア分析、2023年と2030年
  • 腫瘍学
  • 感染症
  • 循環器疾患
  • 自己免疫疾患
  • 免疫不全
  • その他

第7章 ウェアラブル注入器市場:最終用途推定・動向分析

  • ウェアラブル注入器市場:重要なポイント
  • ウェアラブル注入器市場:変動と市場シェア分析、2023年と2030年
  • 病院
  • クリニック
  • ホームケア
  • その他

第8章 ウェアラブル注入器市場:地域推定・動向分析

  • 地域別の見通し
  • 地域別のウェアラブル注入器市場:重要なポイント
  • 北米
    • 市場推計・予測、2018~2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • インド
    • 中国
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • BD
  • Johnson &Johnson Services, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Unilife Corporation
  • Steady Med Therapeutics, Inc.
  • Amgen Inc.
  • Insulet Corporation
  • Enable Injections
  • West Pharmaceutical Services, Inc.
  • CeQur Simplicity
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America wearable injectors market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 9 U.S. wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 10 U.S. wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 13 Canada wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 17 Europe wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe wearable injectors market, by region, 2018 - 2030 (USD Million)
  • Table 20 Germany wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 21 Germany wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Germany wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 23 Germany wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 25 UK wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 26 UK wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 27 UK wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 France wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 29 France wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 30 France wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 31 France wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Italy wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 34 Italy wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Spain wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 37 Spain wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Spain wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 39 Spain wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Sweden wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 41 Sweden wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Sweden wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Norway wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Norway wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 47 Norway wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Denmark wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 49 Denmark wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Denmark wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 51 Denmark wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific wearable injectors market, by region, 2018 - 2030 (USD Million)
  • Table 57 China wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 58 China wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 59 China wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 60 China wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Japan wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 62 Japan wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Japan wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 64 Japan wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 India wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 66 India wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 67 India wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 68 India wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Australia wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 70 Australia wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Australia wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 72 Australia wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Thailand wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 74 Thailand wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 75 Thailand wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 76 Thailand wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 South Korea wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 78 South Korea wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 79 South Korea wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Korea wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Latin America wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 82 Latin America wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Latin America wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 84 Latin America wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Latin America wearable injectors market, by region, 2018 - 2030 (USD Million)
  • Table 86 Brazil wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 87 Brazil wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Brazil wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 89 Brazil wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Mexico wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 91 Mexico wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 92 Mexico wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 93 Mexico wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 94 Argentina wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 95 Argentina wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 96 Argentina wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 97 Argentina wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa wearable injectors market, by region, 2018 - 2030 (USD Million)
  • Table 103 South Africa wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 104 South Africa wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 105 South Africa wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 110 UAE wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 111 UAE wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 112 UAE wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 113 UAE wearable injectors market, by end-use, 2018 - 2030 (USD Million)
  • Table 114 Kuwait wearable injectors market, by type, 2018 - 2030 (USD Million)
  • Table 115 Kuwait wearable injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 116 Kuwait wearable injectors market, by application, 2018 - 2030 (USD Million)
  • Table 117 Kuwait wearable injectors market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Wearable Injectors: market outlook
  • Fig. 9 Wearable Injectors competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Wearable Injectors market driver impact
  • Fig. 15 Wearable Injectors market restraint impact
  • Fig. 16 Wearable Injectors market strategic initiatives analysis
  • Fig. 17 Wearable Injectors market: Type movement analysis
  • Fig. 18 Wearable Injectors market: Type outlook and key takeaways
  • Fig. 19 Solid market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Hollow market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Dissolving market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Coated market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Wearable Injectors market: Technology movement analysis
  • Fig. 25 Wearable Injectors market: Technology outlook and key takeaways
  • Fig. 26 Silicon market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Metal market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Polymer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Wearable Injectors market: Application movement analysis
  • Fig. 31 Wearable Injectors market: Application outlook and key takeaways
  • Fig. 32 Dermatology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Drug delivery market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Pain management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Cancer therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Vaccine delivery market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Global Wearable Injectors market: Regional movement analysis
  • Fig. 39 Global Wearable Injectors market: Regional outlook and key takeaways
  • Fig. 40 Global market share and leading players
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-614-1

Wearable Injectors Market Growth & Trends:

The global wearable injectors market size is expected to reach USD 23.89 billion by 2030, expanding at a CAGR of 18.11 from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period owing to technological advancements in wearable injectors coupled with rising demand for round-the-clock monitoring.

Technological advancements in wearable injectors, for instance, Bluetooth integrated wearable injectors, send alerts to patients, such as injection reminders and data regarding their therapy regime. Also, optional smart functionality provides connectivity to the healthcare network. Some of these devices have buttons that are accessible through clothing, and some devices prevent accidental activation. They also have audible and visual status indicators or signals. Patients can self-administer drugs subcutaneously with minimal time and effort as compared to intravenous or other routes. Patients don't need to visit any healthcare provider for the administration.

The prevalence of lifestyle-associated diseases, such as diabetes and hypertension is expected to increase during the forecast period. These diseases demand round-the-clock monitoring of various physiological parameters, such as blood pressure and blood sugar levels. The advanced ecosystem of these devices helps healthcare care providers to access data from remote location, which reduces clinical decision time. Thus, integration of healthcare data with wearable injectors, which gets forwarded to physicians or doctors giving them real-time access to data with reduced errors, is expected to boost the wearable injectors market.

Wearable Injectors Market Report Highlights:

  • The on-body wearable injectors accounted for the largest revenue share in 2023 owing to the growing preference of the patients for adhesive patches that release the drug conveniently and can be worn on the skin
  • The motor-driven segment is expected to register the highest growth during the forecast period owing to increasing demand from hospitals, clinics, retail chain stores, and pharmacies
  • The oncology segment is expected to hold the largest market share due to the globally increasing incidences of cancer
  • The home care segment is expected to dominate the market with the highest market share owing to increasing inclination towards the home-based treatments onset of COVID-19 pandemic can be seen and it has positively impacted the home care segment growth
  • North America accounted for the largest revenue share of 33.2% in 2023. It is attributed to the rising prevalence of chronic & lifestyle-related diseases and augmented healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Technology
    • 1.1.3. Application
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Application outlook
    • 2.2.4. End-use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Wearable Injectors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Wearable Injectors Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Wearable Injectors Market: Type Estimates & Trend Analysis

  • 4.1. Wearable Injectors Market: Key Takeaways
  • 4.2. Wearable Injectors Market: Movement & Market Share Analysis, 2023 & 2030
  • 4.3. On-body
    • 4.3.1. On-body market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Off-body
    • 4.4.1. Off-body market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Wearable Injectors Market: Technology Estimates & Trend Analysis

  • 5.1. Wearable Injectors Market: Key Takeaways
  • 5.2. Wearable Injectors Market: Movement & Market Share Analysis, 2023 & 2030
  • 5.3. Spring-based
    • 5.3.1. Spring-based market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Motor-driven
    • 5.4.1. Motor-driven market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Rotary Pump
    • 5.5.1. Rotary pump market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Expanding Battery
    • 5.6.1. Expanding battery market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Wearable Injectors Market: Application Estimates & Trend Analysis

  • 6.1. Wearable Injectors Market: Key Takeaways
  • 6.2. Wearable Injectors Market: Movement & Market Share Analysis, 2023 & 2030
  • 6.3. Oncology
    • 6.3.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Infectious Disease
    • 6.4.1. Infectious disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Cardiovascular Disease
    • 6.5.1. Cardiovascular disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Autoimmune Disease
    • 6.6.1. Autoimmune disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Immunodeficiency
    • 6.7.1. Immunodeficiency market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Wearable Injectors Market: End-use Estimates & Trend Analysis

  • 7.1. Wearable Injectors Market: Key Takeaways
  • 7.2. Wearable Injectors Market: Movement & Market Share Analysis, 2023 & 2030
  • 7.3. Hospitals
    • 7.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Clinics
    • 7.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Home Care
    • 7.5.1. Home care market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Wearable Injectors Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Wearable Injectors Market by Region: Key Takeaways
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory framework
      • 8.3.2.4. Reimbursement scenario
      • 8.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory framework
      • 8.3.3.4. Reimbursement scenario
      • 8.3.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Competitive Scenario
      • 8.4.1.3. Regulatory framework
      • 8.4.1.4. Reimbursement scenario
      • 8.4.1.5. UK market estimates and forecasts, 2018 - 2030
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. France market estimates and forecasts, 2018 - 2030
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory framework
      • 8.4.4.4. Reimbursement scenario
      • 8.4.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory framework
      • 8.4.5.4. Reimbursement scenario
      • 8.4.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 8.4.6. Denmark
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory framework
      • 8.4.6.4. Reimbursement scenario
      • 8.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory framework
      • 8.4.7.4. Reimbursement scenario
      • 8.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 8.4.8. Norway
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory framework
      • 8.4.8.4. Reimbursement scenario
      • 8.4.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive Scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. Reimbursement scenario
      • 8.5.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 8.5.2. India
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. India market estimates and forecasts, 2018 - 2030
    • 8.5.3. China
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. China market estimates and forecasts, 2018 - 2030
    • 8.5.4. South Korea
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 8.5.5. Australia
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive Scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Reimbursement scenario
      • 8.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 8.6.2. Mexico
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. Argentina market estimates and forecasts, 2018 - 2030
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive Scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Reimbursement scenario
      • 8.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory framework
      • 8.7.4.4. Reimbursement scenario
      • 8.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

  • 9.1. BD
  • 9.2. Johnson & Johnson Services, Inc.
  • 9.3. F. Hoffmann-La Roche Ltd.
  • 9.4. Unilife Corporation
  • 9.5. Steady Med Therapeutics, Inc.
  • 9.6. Amgen Inc.
  • 9.7. Insulet Corporation
  • 9.8. Enable Injections
  • 9.9. West Pharmaceutical Services, Inc.
  • 9.10. CeQur Simplicity